Fig. 2.
Fig. 2. Percentage tetramer+ EBV-specific T cells and functionality of tetramer+ T cells in HIV−and HIV+ individuals. / (A) The number of tetramer+ (percentage of CD8+T cells as assessed by tetramer staining) and (B) proportion of IFN-γ–producing T cells of tetramer+ T cells (percentage of tetramer+ T cells determined after peptide stimulation) are shown for HIV− (n = 6, filled circles) and HIV+ individuals (n = 11) early in HIV infection (average of time points studied until CD4+ T cells drop below 200/μL or halfway through follow-up). HIV+ individuals include individuals progressing to AIDS-NHL (n = 5, open triangles) or AIDS-OI (n = 3, open circles) and LTA HIV-infected individuals (n = 3, filled triangles).

Percentage tetramer+ EBV-specific T cells and functionality of tetramer+ T cells in HIVand HIV+ individuals.

(A) The number of tetramer+ (percentage of CD8+T cells as assessed by tetramer staining) and (B) proportion of IFN-γ–producing T cells of tetramer+ T cells (percentage of tetramer+ T cells determined after peptide stimulation) are shown for HIV (n = 6, filled circles) and HIV+ individuals (n = 11) early in HIV infection (average of time points studied until CD4+ T cells drop below 200/μL or halfway through follow-up). HIV+ individuals include individuals progressing to AIDS-NHL (n = 5, open triangles) or AIDS-OI (n = 3, open circles) and LTA HIV-infected individuals (n = 3, filled triangles).

Close Modal

or Create an Account

Close Modal
Close Modal